NCT05627661View on ClinicalTrials.gov

Wearable Devices to Monitor Seizures in Autoimmune Epilepsy

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

October 27, 2022

Primary Completion Date

November 22, 2023

Study Completion Date

November 22, 2023

Conditions
Autoimmune EpilepsyHealthy
Interventions
DEVICE

Biosensor

Noninvasive wearable biosensor device worn on the primary affected wrist or upper arm for as much time as is feasible for 7-10 days

Trial Locations (1)

55905

Mayo Clinic Minnesota, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05627661 - Wearable Devices to Monitor Seizures in Autoimmune Epilepsy | Biotech Hunter | Biotech Hunter